Fol. Biol. 2020, 66, 17-23

https://doi.org/10.14712/fb2020066010017

Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma

P. Vockova1,2, M. Svaton3, J. Karolova1,2, E. Pokorna2, Martin Vokurka2, Pavel Klener1,2

11st Department of Medicine – Department of Haematology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
2Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
3CLIP – Laboratory Centre Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

Received October 2019
Accepted January 2020

Individual author index pages


Other articles of these authors

front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive